← Back to Search

Procedure

Central Venous Catheter Techniques for Shock

Phase 4
Recruiting
Led By Benjamin J Friedman, MD
Research Sponsored by Montefiore Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 20 minutes
Awards & highlights

Study Summary

This trial will compare the safety and effectiveness of two different techniques for placing a central venous catheter.

Who is the study for?
This trial is for adult patients in the emergency department who need a central venous catheter placed using ultrasound guidance. People with existing catheters that could interfere, blood clotting issues, low platelet counts, previous central lines at the same site, or conditions affecting consent are not eligible.Check my eligibility
What is being tested?
The study compares two different techniques of inserting a central venous catheter to see which one might be better. Patients will receive one of these techniques when they require a central line during their emergency care.See study design
What are the potential side effects?
Potential side effects from central line insertion include bleeding, infection at the insertion site, injury to nearby structures like arteries or nerves, and complications related to incorrect placement.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~20 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 20 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Only 1 attempt
Secondary outcome measures
Number of attempts
Interventional procedure
Unable to place central line

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Peripheral IVExperimental Treatment1 Intervention
A peripheral intravenous catheter will be used to obtain initial central venous access
Group II: Standard techniqueActive Control1 Intervention
The conventional hollow bore needle on a syringe will be used

Find a Location

Who is running the clinical trial?

Montefiore Medical CenterLead Sponsor
443 Previous Clinical Trials
582,376 Total Patients Enrolled
2 Trials studying Shock
1,751 Patients Enrolled for Shock
Benjamin J Friedman, MDPrincipal InvestigatorMontefiore Medical Center

Media Library

Central venous catheter insertion (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT05534971 — Phase 4
Shock Research Study Groups: Standard technique, Peripheral IV
Shock Clinical Trial 2023: Central venous catheter insertion Highlights & Side Effects. Trial Name: NCT05534971 — Phase 4
Central venous catheter insertion (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05534971 — Phase 4

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research effort still enrolling volunteers?

"According to clinicaltrials.gov, the trial in question is not taking on new patients at present and was last revised November 9th 2022. Despite this, there are still 136 other studies presently recruiting participants."

Answered by AI

What deleterious effects are associated with the insertion of Central venous catheters?

"Based on the Phase 4 clinical trial, our staff assess that Central venous catheter insertion is highly safe and awarded it a score of 3."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Central Line Study
2022. "Central Line Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05534971.
~107 spots leftby Dec 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top